Business Wire
-
Cardio Diagnostics Begins In-House Test Processing At Its New High Complexity CLIA-Certified Laboratory In Iowa City
8/18/2026
Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, today announced the official launch of its in-house, high complexity CLIA-certified laboratory in Iowa City, Iowa.
-
biomodal Launches Duet Mosaic Giving Liquid Biopsy Researchers And Developers More Signal From Every Blood Draw
8/12/2026
biomodal, an omics-based life sciences technology and analytics company, today announced the launch of the duet mosaic family, which includes two new circulating cell-free DNA (cfDNA)-optimized multiomic sequencing workflows for liquid biopsy and translational research.
-
Vivodyne Launches The World's Largest Human Biological Datacenter To Train The First World Model Of Human Biology
8/12/2026
Vivodyne, the company making human biology computable at AI scale, today announced the world’s largest human biological datacenter, with 12 robotic HIVE laboratories and the annual capacity to perform controlled trials on 3.1 million large human tissues per year — estimated at twice the scale of every clinical trial in the USA combined.
-
Amprion Partners With MLM Medical Labs To Expand Alpha-Synuclein SAA Testing In Europe
8/12/2026
Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a strategic licensing collaboration with MLM Medical Labs, a global central and specialty laboratory with operations in Germany.
-
Bruker Announces Strategic Collaboration With Atinary Technologies To Advance Self-Driving Laboratories
8/11/2026
Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials. Bruker also made a minority investment in Atinary.
-
Leeds NHS Innovation To Accelerate Global Adoption Of AI-Enabled Pathology For Cancer Diagnostics Through Epredia Partnership
8/5/2026
A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the UK's National Health Service.
-
LabPMM Launches Global KMT2A MRD Testing Service To Support Menin Inhibitor Development And Acute Leukemia Care
8/4/2026
LabPMM, an Invivoscribe subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.
-
Clinisys Partners With Decisions To Bring Low-Code / No-Code LIMS/LIS Configuration To Laboratory Environments
7/28/2026
Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform.
-
Thermo Fisher Scientific Presents End-To-End Diagnostic And Lab Solutions Addressing Unmet Clinical Needs At ADLM 2026
7/27/2026
Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 26-30, 2026, in Anaheim, Calif.
-
SCIEX Helps Clinical Labs Move From Sample To Answer Faster With New Software And LC Solutions
7/27/2026
SCIEX, a Danaher company and leader in life science analytical technologies, today announced new solutions designed to help clinical laboratories move from sample to answer faster with greater confidence, productivity and control. Introduced at ADLM, the ExionLC MD system and SCIEX OS software for the clinical portfolio simplify complex workflows, automate routine processes, and support the delivery of high-quality patient-critical results.